# Ph 2 Trial of Vitamin C & G-FLIP (Low Doses Gemcitabine, 5FU, Leucovorin, Irinotecan, Oxaliplatin) for Pancreatic Cancer

> **NCT01905150** · PHASE2 · COMPLETED · sponsor: **Bruckner Oncology** · enrollment: 34 (actual)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DRUG:** G-FLIP
- **DRUG:** G-FLIP-DM
- **DIETARY_SUPPLEMENT:** Vitamin C

## Key facts

- **NCT ID:** NCT01905150
- **Lead sponsor:** Bruckner Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08-13
- **Primary completion:** 2020-01
- **Final completion:** 2020-01
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2024-12-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01905150

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01905150, "Ph 2 Trial of Vitamin C & G-FLIP (Low Doses Gemcitabine, 5FU, Leucovorin, Irinotecan, Oxaliplatin) for Pancreatic Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01905150. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*